The metabolic products of intracellular mevalonate (MVA) are important for the growth of eukaryotic cells. These products include cholesterol and several nonsterol isoprenoids. It has been reported that 3hydroxy3methylglutaryl coenzyme A reductase inhibitors ameliorate glomerular
injury in several experimental models of progressive glomerular disease by inhibiting the production of MVA and its metabolites. However, the mechanisms by which MVA stimulates the growth of human mesangial cells (HMCs) remain to be elucidated. To investigate the role of MVA in HMC proliferation,
apoptosis, cell cycle and accumulation of extracellular matrix (ECM), the effects of MVA on HMCs at different durations and at various doses were evaluated. To examine the mechanisms of the effects of MVA on HMCs, the cells were treated with MVA, with or without PD98059, an extracellular signalregulated
kinase (ERK) inhibitor, SP600125, cJun NH2teminal kinase (JNK) inhibitor, or SB203580, a P38 mitogenactivated protein kinase (MAPK) inhibitor. A 3(4,5dimethylthiazol2yl)2,5diphenyl tetrazolium bromide reduction assay was used to measure the proliferation of the HMCs, a flow cytometric
assay was used to assess the proliferative index, and an ELISA was performed to determine the expression of transforming growth factorβ1 (TGFβ1), Type and Type I collagen (Col and ColI). The expression of Bcell lymphoma 2 (Bcl2), Bcl2associated X protein (Bax), phosphorylated
(p)ERK1/2, pJNK and pp38 were also examined using western blot analysis. MVA significantly stimulated HMC proliferation and markedly increased the secretion of TGFβ1 and expression levels of Col and ColI. In addition, treatment with MVA significantly upregulated the expression of Bcl2
and suppressed the expression of Bax in the HMCs. These responses were partially inhibited by the addition of inhibitors of ERK or JNK, however, they were not inhibited by the p38 MAPK inhibitor. These results demonstrated that MVA promoted HMC proliferation and ECM protein expression,
which were associated with an increase in the expression of TGFβ1 and the inhibition of apoptosis. These effects were mediated, at least in part, by the JNK and ERK pathways.
No Reference information available - sign in for access.
No Citation information available - sign in for access.
No Supplementary Data.
No Article Media
Document Type: Research Article
Department of Nephrology, Provincial People's Hospital of Shanxi Medical University, Shanxi Provincial People's Hospital, Shanxi Kidney Disease Institute, Taiyuan, Shanxi 030001, P.R. China
Department of Pathology, The Second Hospital of Shanxi Medical University, Taiyuan, Shanxi 030001, P.R. China
Department of Microbiology and Immunology, Shanxi Medical University, Taiyuan, Shanxi 030001, P.R. China
Department of Nephrology, Baylor College of Medicine, Houston, TX 77030, USA
Publication date: August 1, 2015
More about this publication?
Molecular Medicine Reports is a monthly, peer-reviewed journal available in print and online, that includes studies devoted to molecular medicine, underscoring aspects including pharmacology, pathology, genetics, neurosciences, infectious diseases, molecular cardiology and molecular surgery. In vitro and in vivo studies of experimental model systems pertaining to the mechanisms of a variety of diseases offer researchers the necessary tools and knowledge with which to aid the diagnosis and treatment of human diseases.
- Editorial Board
- Information for Authors
- Submit a Paper
- Subscribe to this Title
- Information for Advertisers
- Terms & Conditions
- Ingenta Connect is not responsible for the content or availability of external websites